120 related articles for article (PubMed ID: 24429460)
21. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of visually identifiable 18F-fluorodeoxyglucose uptake in primary papillary thyroid microcarcinoma.
Hwang SO; Lee SW; Kang JK; Choi HH; Kim WW; Park HY; Jung JH
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):415-20. PubMed ID: 24903453
[TBL] [Abstract][Full Text] [Related]
23. Malignant pleural mesothelioma with heterologous osteoblastic elements: computed tomography, magnetic resonance, and positron emission tomography imaging characteristics of a rare tumor.
Salgado RA; Corthouts R; Parizel PM; Germonpré P; Carp L; Van Schil P; Van Marck E
J Comput Assist Tomogr; 2005; 29(5):653-6. PubMed ID: 16163037
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of (131)INa activity in renal cysts unrelated to metastatic disease in a patient with differentiated thyroid cancer.
Castillo-Berrio C; Zelaya F; Loira F; Castrillón M; López A; Outomuro J
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):70-1. PubMed ID: 26144698
[No Abstract] [Full Text] [Related]
26. Unusual muscular metastases from papillary thyroid carcinoma detected by fluorine-18-fluorodeoxyglucose PET/MRI.
Ceriani L; Treglia G; Paone G; Bongiovanni M; Franscella S; Giovanella L
J Clin Endocrinol Metab; 2013 Jun; 98(6):2208-9. PubMed ID: 23596135
[No Abstract] [Full Text] [Related]
27. Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.
Lloret Linares C; Troisvallets D; Sellier P; Aurengo A; Leenhardt L
Med Oncol; 2010 Sep; 27(3):756-9. PubMed ID: 19657751
[TBL] [Abstract][Full Text] [Related]
28. Tc-99m tetrofosmin uptake by recurrent papillary carcinoma of the thyroid.
Erdem S; Baskan A; Baŝhekim C; Filiz E
Clin Nucl Med; 1998 Mar; 23(3):189. PubMed ID: 9509945
[No Abstract] [Full Text] [Related]
29. Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography.
Murray JG; Erasmus JJ; Bahtiarian EA; Goodman PC
AJR Am J Roentgenol; 1997 Feb; 168(2):359-60. PubMed ID: 9016206
[No Abstract] [Full Text] [Related]
30. [Use of 18F FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative ¹³¹I scan].
Sanz Viedma S; Borrego Dorado I; Rodríguez Rodríguez JR; Navarro González E; Vázquez Albertino R; Fernández López R; Agudo Martínez A
Rev Esp Med Nucl; 2011; 30(2):77-82. PubMed ID: 21334773
[TBL] [Abstract][Full Text] [Related]
31. [Typical growth pattern in malignant pleural mesothelioma].
Berg AS; Løndalen A; Brustugun OT
Tidsskr Nor Laegeforen; 2015 Jun; 135(11):1050. PubMed ID: 26080781
[No Abstract] [Full Text] [Related]
32. [Pleural metastasis as presenting form of papillary thyroid microcarcinoma: an exceptional case].
Pérez Vega C; Lecube Torelló A; Narváez García J; Vilaseca Momplet J
Rev Clin Esp; 2003 Apr; 203(4):217-8. PubMed ID: 12681214
[No Abstract] [Full Text] [Related]
33. eComment: What is the best way to diagnose and stage malignant pleural mesothelioma?
Cafarotti S; Porziella V; Margaritora S; Granone P
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):811. PubMed ID: 21555444
[No Abstract] [Full Text] [Related]
34. Solitary lung metastasis diagnosed 30 years after surgery for thyroid cancer.
Shigematsu H; Andou A; Teramoto A; Matsuo K; Oda W; Yamadori I; Higashi R
Ann Thorac Surg; 2009 Dec; 88(6):2016-7. PubMed ID: 19932283
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.
Kraeber-Bodéré F; Cariou B; Curtet C; Bridji B; Rousseau C; Dravet F; Charbonnel B; Carnaille B; Le Néel JC; Mirallié E
Surgery; 2005 Dec; 138(6):1176-82; discussion 1182. PubMed ID: 16360406
[TBL] [Abstract][Full Text] [Related]
36. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Scott GC; Meier DA; Dickinson CZ
J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
[TBL] [Abstract][Full Text] [Related]
37. [Pathological thyroid uptake in Cushing's syndrome: an unexpected finding].
Civantos Modino S; Montaño Martínez J; Pavón de Paz I; Guijarro de Armas G; Monereo Megías S
Endocrinol Nutr; 2011; 58(6):315-7. PubMed ID: 21497569
[No Abstract] [Full Text] [Related]
38. Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
Kohlfuerst S; Igerc I; Gallowitsch HJ; Gomez I; Kresnik E; Matschnig S; Lind P
Thyroid; 2006 Nov; 16(11):1113-9. PubMed ID: 17123338
[TBL] [Abstract][Full Text] [Related]
39. [Diffuse sclerosing variant of papillary thyroid carcinoma].
Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
[No Abstract] [Full Text] [Related]
40. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
